87
70
Growth Score
-4 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
471850
MOYA Bio is developing novel E1 inhibitors for solid and hematological malignancies.
Eyal Ben Ami: Chief Scientific Officer
About the Company
MOYA Bio is developing novel E1 inhibitors for solid and hematological malignancies. The company's unique drugs are designed to target and selectively modify the Ubiquitin and Ubiquitin-Like (UBL) pathways, resulting in direct anti-tumor actions while also enhancing the effectiveness of other therapeutic methods.
